LIST OF TABLES
TABLE 1 EMERGING DRUGS FOR THE TREATMENT OF SYMPTOMS RELATED TO BLAU SYNDROME
TABLE 2 GENERIC DRUGS FOR CARDIAC SARCOIDOSIS TREATMENT
TABLE 3 GLOBAL BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 4 GLOBAL TREATMENT IN BLAU SYNDROME MARKET, BY REGION, 2018-2027 (USD THOUSAND)
TABLE 5 GLOBAL TREATMENT IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 6 GLOBAL CORTICOSTEROIDS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 7 GLOBAL IMMUNOSUPPRESSANTS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 8 GLOBAL TNF-Α INHIBITORS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 9 GLOBAL OPHTHALMIC MEDICATION IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 10 GLOBAL INTERLEUKIN RECEPTOR IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 11 GLOBAL DIAGNOSIS IN BLAU SYNDROME MARKET, BY REGION, 2018-2027 (USD THOUSAND)
TABLE 12 GLOBAL BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 13 GLOBAL SCREENING IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 14 GLOBAL LAB TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 15 GLOBAL IMAGING TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 16 GLOBAL CONFIRMATORY TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 17 GLOBAL BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 18 GLOBAL SKIN RASH IN BLAU SYNDROME MARKET, BY REGION, 2018-2027 (USD THOUSAND)
TABLE 19 GLOBAL INFLAMMATION IN BLAU SYNDROME MARKET, BY REGION, 2018-2027 (USD THOUSAND)
TABLE 20 NORTH AMERICA INFLAMMATION IN BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 21 GLOBAL TREATMENT IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION , 2017-2026 (USD THOUSAND)
TABLE 22 GLOBAL ORAL IN BLAU SYNDROME MARKET, BY REGION, 2017-2026 (USD THOUSAND)
TABLE 23 GLOBAL ORAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD THOUSAND)
TABLE 24 GLOBAL PARENTERAL IN BLAU SYNDROME MARKET, BY REGION, 2017-2026 (USD THOUSAND)
TABLE 25 GLOBAL PARENTERAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD THOUSAND)
TABLE 26 GLOBA TOPICAL IN BLAU SYNDROME MARKET, BY REGION, 2017-2026 (USD THOUSAND)
TABLE 27 GLOBAL TOPICAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD THOUSAND)
TABLE 28 GLOBAL OTHERS IN BLAU SYNDROME MARKET, BY REGION, 2017-2026 (USD THOUSAND)
TABLE 29 GLOBAL BLAU SYNDROME MARKET, BY END USER, 2018-2027 (USD THOUSAND)
TABLE 30 GLOBAL HOSPITALS IN BLAU SYNDROME MARKET, BY REGION, 2018-2027 (USD THOUSAND)
TABLE 31 GLOBAL ONLINE PHARMACY IN BLAU SYNDROME MARKET, BY REGION, 2018-2027 (USD THOUSAND)
TABLE 32 GLOBAL CLINICS IN BLAU SYNDROME MARKET, BY REGION, 2018-2027 (USD THOUSAND)
TABLE 33 GLOBAL HOME HEALTH CARE IN BLAU SYNDROME MARKET, BY REGION, 2018-2027 (USD THOUSAND)
TABLE 34 GLOBAL OTHERS IN BLAU SYNDROME MARKET, BY REGION, 2018-2027 (USD THOUSAND)
TABLE 35 GLOBAL BLAU SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
TABLE 36 GLOBAL HOSPITAL PHARMACY IN BLAU SYNDROME MARKET, BY REGION, 2018-2027 (USD THOUSAND)
TABLE 37 GLOBAL RETAIL PHARMACY IN BLAU SYNDROME MARKET, BY REGION, 2018-2027 (USD THOUSAND)
TABLE 38 GLOBAL ONLINE PHARMACY IN BLAU SYNDROME MARKET, BY REGION, 2018-2027 (USD THOUSAND)
TABLE 39 GLOBAL DIRECT TENDER IN BLAU SYNDROME MARKET, BY REGION, 2018-2027 (USD THOUSAND)
TABLE 40 GLOBAL OTHERS IN BLAU SYNDROME MARKET, BY REGION, 2018-2027 (USD THOUSAND)
TABLE 41 GLOBAL BLAU SYNDROME MARKET, BY REGION, 2018-2027 (USD THOUSAND)
TABLE 42 NORTH AMERICA BLAU SYNDROME MARKET, BY COUNTRY, 2018-2027 (USD THOUSAND)
TABLE 43 NORTH AMERICA BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 44 NORTH AMERICA DIAGNOSIS IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 45 NORTH AMERICA SCREENING IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 46 NORTH AMERICA LAB TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 47 NORTH AMERICA IMAGING TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 48 NORTH AMERICA CONFIRMATORY TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 49 NORTH AMERICA TREATMENT IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 50 NORTH AMERICA CORTICOSTEROIDS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 51 NORTH AMERICA IMMUNOSUPPRESSANTS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 52 NORTH AMERICA TNF-Α INHIBITORS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 53 NORTH AMERICA OPHTHALMIC MEDICATION IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 54 NORTH AMERICA INTERLEUKIN RECEPTOR IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 55 NORTH AMERICA BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 56 NORTH AMERICA INFLAMMATION IN BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 57 NORTH AMERICA BLAU SYNDROME , BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 58 NORTH AMERICA ORAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 59 NORTH AMERICA PARENTERAL BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 60 NORTH AMERICA TOPICAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 61 NORTH AMERICA BLAU SYNDROME MARKET, BY END USER, 2018-2027 (USD THOUSAND)
TABLE 62 NORTH AMERICA BLAU SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
TABLE 63 U.S. BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 64 U.S. DIAGNOSIS IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 65 U.S. SCREENING IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 66 U.S. LAB TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 67 U.S. IMAGING TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 68 U.S. CONFIRMATORY TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 69 U.S. TREATMENT IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 70 U.S. CORTICOSTEROIDS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 71 U.S. IMMUNOSUPPRESSANTS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 72 U.S. TNF-Α INHIBITORS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 73 U.S. OPHTHALMIC MEDICATION IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 74 U.S. INTERLEUKIN RECEPTOR IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 75 U.S. BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 76 U.S. INFLAMMATION IN BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 77 U.S. TREATMENT IN BLAU SYNDROME , BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 78 U.S. ORAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 79 U.S. PARENTERAL BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 80 U.S. TOPICAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 81 U.S. BLAU SYNDROME MARKET, BY END USER, 2018-2027 (USD THOUSAND)
TABLE 82 U.S. BLAU SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
TABLE 83 CANADA BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 84 CANADA DIAGNOSIS IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 85 CANADA SCREENING IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 86 CANADA LAB TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 87 CANADA IMAGING TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 88 CANADA CONFIRMATORY TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 89 CANADA TREATMENT IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 90 CANADA CORTICOSTEROIDS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 91 CANADA IMMUNOSUPPRESSANTS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 92 CANADA TNF-Α INHIBITORS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 93 CANADA OPHTHALMIC MEDICATION IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 94 CANADA INTERLEUKIN RECEPTOR IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 95 CANADA BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 96 CANADA INFLAMMATION IN BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 97 CANADA TREATMENT IN BLAU SYNDROME , BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 98 CANADA ORAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 99 CANADA PARENTERAL BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 100 CANADA TOPICAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 101 CANADA BLAU SYNDROME MARKET, BY END USER, 2018-2027 (USD THOUSAND)
TABLE 102 CANADA BLAU SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
TABLE 103 MEXICO BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 104 MEXICO DIAGNOSIS IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 105 MEXICO SCREENING IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 106 MEXICO LAB TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 107 MEXICO IMAGING TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 108 MEXICO CONFIRMATORY TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 109 MEXICO TREATMENT IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 110 MEXICO CORTICOSTEROIDS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 111 MEXICO IMMUNOSUPPRESSANTS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 112 MEXICO TNF-Α INHIBITORS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 113 MEXICO OPHTHALMIC MEDICATION IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 114 MEXICO INTERLEUKIN RECEPTOR IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 115 MEXICO BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 116 MEXICO INFLAMMATION IN BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 117 MEXICO TREATMENT IN BLAU SYNDROME , BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 118 MEXICO ORAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 119 MEXICO PARENTERAL BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 120 MEXICO TOPICAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 121 MEXICO BLAU SYNDROME MARKET, BY END USER, 2018-2027 (USD THOUSAND)
TABLE 122 MEXICO BLAU SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
TABLE 123 EUROPE BLAU SYNDROME MARKET, BY COUNTRY, 2018-2027 (USD THOUSAND)
TABLE 124 EUROPE BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 125 EUROPE DIAGNOSIS IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 126 EUROPE SCREENING IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 127 EUROPE LAB TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 128 EUROPE IMAGING TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 129 EUROPE CONFIRMATORY TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 130 EUROPE TREATMENT IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 131 EUROPE CORTICOSTEROIDS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 132 EUROPE IMMUNOSUPPRESSANTS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 133 EUROPE TNF-Α INHIBITORS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 134 EUROPE OPHTHALMIC MEDICATION IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 135 EUROPE INTERLEUKIN RECEPTOR IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 136 EUROPE BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 137 EUROPE INFLAMMATION IN BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 138 EUROPE TREATMENT IN BLAU SYNDROME , BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 139 EUROPE ORAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 140 EUROPE PARENTERAL BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 141 EUROPE TOPICAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 142 EUROPE BLAU SYNDROME MARKET, BY END USER, 2018-2027 (USD THOUSAND)
TABLE 143 EUROPE BLAU SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
TABLE 144 GERMANY BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 145 GERMANY DIAGNOSIS IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 146 GERMANY SCREENING IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 147 GERMANY LAB TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 148 GERMANY IMAGING TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 149 GERMANY CONFIRMATORY TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 150 GERMANY TREATMENT IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 151 GERMANY CORTICOSTEROIDS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 152 GERMANY IMMUNOSUPPRESSANTS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 153 GERMANY TNF-Α INHIBITORS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 154 GERMANY OPHTHALMIC MEDICATION IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 155 GERMANY INTERLEUKIN RECEPTOR IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 156 GERMANY BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 157 GERMANY INFLAMMATION IN BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 158 GERMANY TREATMENT IN BLAU SYNDROME , BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 159 GERMANY ORAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 160 GERMANY PARENTERAL BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 161 GERMANY TOPICAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 162 GERMANY BLAU SYNDROME MARKET, BY END USER, 2018-2027 (USD THOUSAND)
TABLE 163 GERMANY BLAU SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
TABLE 164 FRANCE BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 165 FRANCE DIAGNOSIS IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 166 FRANCE SCREENING IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 167 FRANCE LAB TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 168 FRANCE IMAGING TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 169 FRANCE CONFIRMATORY TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 170 FRANCE TREATMENT IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 171 FRANCE CORTICOSTEROIDS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 172 FRANCE IMMUNOSUPPRESSANTS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 173 FRANCE TNF-Α INHIBITORS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 174 FRANCE OPHTHALMIC MEDICATION IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 175 FRANCE INTERLEUKIN RECEPTOR IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 176 FRANCE BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 177 FRANCE INFLAMMATION IN BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 178 FRANCE TREATMENT IN BLAU SYNDROME , BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 179 FRANCE ORAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 180 FRANCE PARENTERAL BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 181 FRANCE TOPICAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 182 FRANCE BLAU SYNDROME MARKET, BY END USER, 2018-2027 (USD THOUSAND)
TABLE 183 FRANCE BLAU SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
TABLE 184 U.K. BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 185 U.K. DIAGNOSIS IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 186 U.K. SCREENING IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 187 U.K. LAB TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 188 U.K. IMAGING TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 189 U.K. CONFIRMATORY TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 190 U.K. TREATMENT IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 191 U.K. CORTICOSTEROIDS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 192 U.K. IMMUNOSUPPRESSANTS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 193 U.K. TNF-Α INHIBITORS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 194 U.K. OPHTHALMIC MEDICATION IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 195 U.K. INTERLEUKIN RECEPTOR IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 196 U.K. BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 197 U.K. INFLAMMATION IN BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 198 U.K. TREATMENT IN BLAU SYNDROME , BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 199 U.K. ORAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 200 U.K. PARENTERAL BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 201 U.K. TOPICAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 202 U.K. BLAU SYNDROME MARKET, BY END USER, 2018-2027 (USD THOUSAND)
TABLE 203 U.K. BLAU SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
TABLE 204 ITALYBLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 205 ITALYDIAGNOSIS IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 206 ITALYSCREENING IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 207 ITALYLAB TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 208 ITALYIMAGING TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 209 ITALYCONFIRMATORY TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 210 ITALYTREATMENT IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 211 ITALYCORTICOSTEROIDS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 212 ITALYIMMUNOSUPPRESSANTS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 213 ITALY TNF-Α INHIBITORS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 214 ITALYOPHTHALMIC MEDICATION IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 215 ITALYINTERLEUKIN RECEPTOR IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 216 ITALYBLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 217 ITALYINFLAMMATION IN BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 218 ITALY TREATMENT IN BLAU SYNDROME , BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 219 ITALYORAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 220 ITALYPARENTERAL BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 221 ITALYTOPICAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 222 ITALY BLAU SYNDROME MARKET, BY END USER, 2018-2027 (USD THOUSAND)
TABLE 223 ITALYBLAU SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
TABLE 224 NETHERLANDS BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 225 NETHERLANDS DIAGNOSIS IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 226 NETHERLANDS SCREENING IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 227 NETHERLANDS LAB TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 228 NETHERLANDS IMAGING TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 229 NETHERLANDS CONFIRMATORY TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 230 NETHERLANDS TREATMENT IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 231 NETHERLANDS CORTICOSTEROIDS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 232 NETHERLANDS IMMUNOSUPPRESSANTS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 233 NETHERLANDS TNF-Α INHIBITORS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 234 NETHERLANDS OPHTHALMIC MEDICATION IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 235 NETHERLANDS INTERLEUKIN RECEPTOR IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 236 NETHERLANDS BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 237 NETHERLANDS INFLAMMATION IN BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 238 NETHERLANDS TREATMENT IN BLAU SYNDROME , BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 239 NETHERLANDS ORAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 240 NETHERLANDS PARENTERAL BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 241 NETHERLANDS TOPICAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 242 NETHERLANDS BLAU SYNDROME MARKET, BY END USER, 2018-2027 (USD THOUSAND)
TABLE 243 NETHERLANDS BLAU SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
TABLE 244 SPAIN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 245 SPAIN DIAGNOSIS IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 246 SPAIN SCREENING IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 247 SPAIN LAB TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 248 SPAIN IMAGING TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 249 SPAIN CONFIRMATORY TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 250 SPAIN TREATMENT IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 251 SPAIN CORTICOSTEROIDS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 252 SPAIN IMMUNOSUPPRESSANTS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 253 SPAIN TNF-Α INHIBITORS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 254 SPAIN OPHTHALMIC MEDICATION IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 255 SPAIN INTERLEUKIN RECEPTOR IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 256 SPAIN BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 257 SPAIN INFLAMMATION IN BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 258 SPAIN TREATMENT IN BLAU SYNDROME , BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 259 SPAIN ORAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 260 SPAIN PARENTERAL BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 261 SPAIN TOPICAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 262 SPAIN BLAU SYNDROME MARKET, BY END USER, 2018-2027 (USD THOUSAND)
TABLE 263 SPAIN BLAU SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
TABLE 264 RUSSIA BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 265 RUSSIA DIAGNOSIS IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 266 RUSSIA SCREENING IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 267 RUSSIA LAB TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 268 RUSSIA IMAGING TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 269 RUSSIA CONFIRMATORY TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 270 RUSSIA TREATMENT IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 271 RUSSIA CORTICOSTEROIDS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 272 RUSSIA IMMUNOSUPPRESSANTS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 273 RUSSIA TNF-Α INHIBITORS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 274 RUSSIA OPHTHALMIC MEDICATION IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 275 RUSSIA INTERLEUKIN RECEPTOR IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 276 RUSSIA BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 277 RUSSIA INFLAMMATION IN BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 278 RUSSIA TREATMENT IN BLAU SYNDROME , BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 279 RUSSIA ORAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 280 RUSSIA PARENTERAL BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 281 RUSSIA TOPICAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 282 RUSSIA BLAU SYNDROME MARKET, BY END USER, 2018-2027 (USD THOUSAND)
TABLE 283 RUSSIA BLAU SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
TABLE 284 SWITZERLAND BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 285 SWITZERLAND DIAGNOSIS IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 286 SWITZERLAND SCREENING IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 287 SWITZERLAND LAB TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 288 SWITZERLAND IMAGING TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 289 SWITZERLAND CONFIRMATORY TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 290 SWITZERLAND TREATMENT IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 291 SWITZERLAND CORTICOSTEROIDS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 292 SWITZERLAND IMMUNOSUPPRESSANTS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 293 SWITZERLAND TNF-Α INHIBITORS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 294 SWITZERLAND OPHTHALMIC MEDICATION IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 295 SWITZERLAND INTERLEUKIN RECEPTOR IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 296 SWITZERLAND BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 297 SWITZERLAND INFLAMMATION IN BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 298 SWITZERLAND TREATMENT IN BLAU SYNDROME , BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 299 SWITZERLAND ORAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 300 SWITZERLAND PARENTERAL BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 301 SWITZERLAND TOPICAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 302 SWITZERLAND BLAU SYNDROME MARKET, BY END USER, 2018-2027 (USD THOUSAND)
TABLE 303 SWITZERLAND BLAU SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
TABLE 304 TURKEY BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 305 TURKEY DIAGNOSIS IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 306 TURKEY SCREENING IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 307 TURKEY LAB TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 308 TURKEY IMAGING TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 309 TURKEY CONFIRMATORY TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 310 TURKEY TREATMENT IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 311 TURKEY CORTICOSTEROIDS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 312 TURKEY IMMUNOSUPPRESSANTS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 313 TURKEY TNF-Α INHIBITORS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 314 TURKEY OPHTHALMIC MEDICATION IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 315 TURKEY INTERLEUKIN RECEPTOR IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 316 TURKEY BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 317 TURKEY INFLAMMATION IN BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 318 TURKEY TREATMENT IN BLAU SYNDROME , BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 319 TURKEY ORAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 320 TURKEY PARENTERAL BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 321 TURKEY TOPICAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 322 TURKEY BLAU SYNDROME MARKET, BY END USER, 2018-2027 (USD THOUSAND)
TABLE 323 TURKEY BLAU SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
TABLE 324 AUSTRIA BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 325 AUSTRIA DIAGNOSIS IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 326 AUSTRIA SCREENING IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 327 AUSTRIA LAB TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 328 AUSTRIA IMAGING TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 329 AUSTRIA CONFIRMATORY TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 330 AUSTRIA TREATMENT IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 331 AUSTRIA CORTICOSTEROIDS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 332 AUSTRIA IMMUNOSUPPRESSANTS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 333 AUSTRIA TNF-Α INHIBITORS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 334 AUSTRIA OPHTHALMIC MEDICATION IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 335 AUSTRIA INTERLEUKIN RECEPTOR IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 336 AUSTRIA BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 337 AUSTRIA INFLAMMATION IN BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 338 AUSTRIA TREATMENT IN BLAU SYNDROME , BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 339 AUSTRIA ORAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 340 AUSTRIA PARENTERAL BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 341 AUSTRIA TOPICAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 342 AUSTRIA BLAU SYNDROME MARKET, BY END USER, 2018-2027 (USD THOUSAND)
TABLE 343 AUSTRIA BLAU SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
TABLE 344 NORWAY BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 345 NORWAY DIAGNOSIS IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 346 NORWAY SCREENING IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 347 NORWAY LAB TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 348 NORWAY IMAGING TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 349 NORWAY CONFIRMATORY TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 350 NORWAY TREATMENT IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 351 NORWAY CORTICOSTEROIDS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 352 NORWAY IMMUNOSUPPRESSANTS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 353 NORWAY TNF-Α INHIBITORS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 354 NORWAY OPHTHALMIC MEDICATION IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 355 NORWAY INTERLEUKIN RECEPTOR IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 356 NORWAY BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 357 NORWAY INFLAMMATION IN BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 358 NORWAY TREATMENT IN BLAU SYNDROME , BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 359 NORWAY ORAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 360 NORWAY PARENTERAL BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 361 NORWAY TOPICAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 362 NORWAY BLAU SYNDROME MARKET, BY END USER, 2018-2027 (USD THOUSAND)
TABLE 363 NORWAY BLAU SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
TABLE 364 HUNGARY BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 365 HUNGARY DIAGNOSIS IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 366 HUNGARY SCREENING IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 367 HUNGARY LAB TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 368 HUNGARY IMAGING TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 369 HUNGARY CONFIRMATORY TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 370 HUNGARY TREATMENT IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 371 HUNGARY CORTICOSTEROIDS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 372 HUNGARY IMMUNOSUPPRESSANTS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 373 HUNGARY TNF-Α INHIBITORS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 374 HUNGARY OPHTHALMIC MEDICATION IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 375 HUNGARY INTERLEUKIN RECEPTOR IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 376 HUNGARY BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 377 HUNGARY INFLAMMATION IN BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 378 HUNGARY TREATMENT IN BLAU SYNDROME , BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 379 HUNGARY ORAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 380 HUNGARY PARENTERAL BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 381 HUNGARY TOPICAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 382 HUNGARY BLAU SYNDROME MARKET, BY END USER, 2018-2027 (USD THOUSAND)
TABLE 383 HUNGARY BLAU SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
TABLE 384 LITHUANIA BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 385 LITHUANIA DIAGNOSIS IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 386 LITHUANIA SCREENING IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 387 LITHUANIA LAB TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 388 LITHUANIA IMAGING TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 389 LITHUANIA CONFIRMATORY TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 390 LITHUANIA TREATMENT IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 391 LITHUANIA CORTICOSTEROIDS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 392 LITHUANIA IMMUNOSUPPRESSANTS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 393 LITHUANIA TNF-Α INHIBITORS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 394 LITHUANIA OPHTHALMIC MEDICATION IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 395 LITHUANIA INTERLEUKIN RECEPTOR IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 396 LITHUANIA BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 397 LITHUANIA INFLAMMATION IN BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 398 LITHUANIA TREATMENT IN BLAU SYNDROME , BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 399 LITHUANIA ORAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 400 LITHUANIA PARENTERAL BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 401 LITHUANIA TOPICAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 402 LITHUANIA BLAU SYNDROME MARKET, BY END USER, 2018-2027 (USD THOUSAND)
TABLE 403 LITHUANIA BLAU SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
TABLE 404 IRELAND BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 405 IRELAND DIAGNOSIS IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 406 IRELAND SCREENING IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 407 IRELAND LAB TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 408 IRELAND IMAGING TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 409 IRELAND CONFIRMATORY TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 410 IRELAND TREATMENT IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 411 IRELAND CORTICOSTEROIDS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 412 IRELAND IMMUNOSUPPRESSANTS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 413 IRELAND TNF-Α INHIBITORS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 414 IRELAND OPHTHALMIC MEDICATION IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 415 IRELAND INTERLEUKIN RECEPTOR IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 416 IRELAND BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 417 IRELAND INFLAMMATION IN BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 418 IRELAND TREATMENT IN BLAU SYNDROME , BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 419 IRELAND ORAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 420 IRELAND PARENTERAL BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 421 IRELAND TOPICAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 422 IRELANDBLAU SYNDROME MARKET, BY END USER, 2018-2027 (USD THOUSAND)
TABLE 423 IRELAND BLAU SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
TABLE 424 POLAND BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 425 POLAND DIAGNOSIS IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 426 POLAND SCREENING IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 427 POLAND LAB TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 428 POLAND IMAGING TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 429 POLAND CONFIRMATORY TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 430 POLAND TREATMENT IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 431 POLAND CORTICOSTEROIDS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 432 POLAND IMMUNOSUPPRESSANTS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 433 POLAND TNF-Α INHIBITORS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 434 POLAND OPHTHALMIC MEDICATION IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 435 POLAND INTERLEUKIN RECEPTOR IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 436 POLAND BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 437 POLAND INFLAMMATION IN BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 438 POLANDTREATMENT IN BLAU SYNDROME , BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 439 POLAND ORAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 440 POLAND PARENTERAL BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 441 POLAND TOPICAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 442 POLAND BLAU SYNDROME MARKET, BY END USER, 2018-2027 (USD THOUSAND)
TABLE 443 POLAND BLAU SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
TABLE 444 REST OF EUROPE BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 445 ASIA PACIFIC BLAU SYNDROME MARKET, BY COUNTRY, 2018-2027 (USD THOUSAND)
TABLE 446 ASIA PACIFIC BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 447 ASIA PACIFIC DIAGNOSIS IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 448 ASIA PACIFIC SCREENING IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 449 ASIA PACIFIC LAB TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 450 ASIA PACIFIC IMAGING TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 451 ASIA PACIFIC CONFIRMATORY TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 452 ASIA PACIFIC TREATMENT IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 453 ASIA PACIFIC CORTICOSTEROIDS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 454 ASIA PACIFIC IMMUNOSUPPRESSANTS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 455 ASIA PACIFIC TNF-Α INHIBITORS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 456 ASIA PACIFIC OPHTHALMIC MEDICATION IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 457 ASIA PACIFIC INTERLEUKIN RECEPTOR IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 458 ASIA PACIFIC BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 459 ASIA PACIFIC INFLAMMATION IN BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 460 ASIA-PACIFIC TREATMENT IN BLAU SYNDROME , BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 461 ASIA PACIFIC ORAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 462 ASIA PACIFIC PARENTERAL BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 463 ASIA PACIFICTOPICAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 464 ASIA-PACIFIC BLAU SYNDROME MARKET, BY END USER, 2018-2027 (USD THOUSAND)
TABLE 465 ASIA PACIFIC BLAU SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
TABLE 466 JAPAN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 467 JAPAN DIAGNOSIS IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 468 JAPAN SCREENING IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 469 JAPAN LAB TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 470 JAPAN IMAGING TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 471 JAPAN CONFIRMATORY TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 472 JAPAN TREATMENT IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 473 JAPAN CORTICOSTEROIDS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 474 JAPAN IMMUNOSUPPRESSANTS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 475 JAPAN TNF-Α INHIBITORS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 476 JAPAN OPHTHALMIC MEDICATION IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 477 JAPAN INTERLEUKIN RECEPTOR IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 478 JAPAN BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 479 JAPAN INFLAMMATION IN BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 480 JAPAN TREATMENT IN BLAU SYNDROME , BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 481 JAPAN ORAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 482 JAPAN PARENTERAL BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 483 JAPAN TOPICAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 484 JAPAN BLAU SYNDROME MARKET, BY END USER, 2018-2027 (USD THOUSAND)
TABLE 485 JAPAN BLAU SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
TABLE 486 CHINA BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 487 CANADA DIAGNOSIS IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 488 CHINA SCREENING IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 489 CHINA LAB TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 490 CHINA IMAGING TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 491 CHINA CONFIRMATORY TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 492 CHINA TREATMENT IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 493 CHINA CORTICOSTEROIDS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 494 CHINA IMMUNOSUPPRESSANTS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 495 CHINA TNF-Α INHIBITORS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 496 CHINA OPHTHALMIC MEDICATION IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 497 CHINA INTERLEUKIN RECEPTOR IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 498 CHINA BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 499 CHINA INFLAMMATION IN BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 500 CHINA TREATMENT IN BLAU SYNDROME , BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 501 CHINA ORAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 502 CHINA PARENTERAL BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 503 CHINA TOPICAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 504 CHINA BLAU SYNDROME MARKET, BY END USER, 2018-2027 (USD THOUSAND)
TABLE 505 CHINA BLAU SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
TABLE 506 AUSTRALIA BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 507 AUSTRALIA DIAGNOSIS IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 508 AUSTRALIA SCREENING IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 509 AUSTRALIA LAB TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 510 AUSTRALIA IMAGING TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 511 AUSTRALIA CONFIRMATORY TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 512 AUSTRALIA TREATMENT IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 513 AUSTRALIA CORTICOSTEROIDS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 514 AUSTRALIA IMMUNOSUPPRESSANTS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 515 AUSTRALIA TNF-Α INHIBITORS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 516 AUSTRALIA OPHTHALMIC MEDICATION IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 517 AUSTRALIA INTERLEUKIN RECEPTOR IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 518 AUSTRALIA BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 519 AUSTRALIA INFLAMMATION IN BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 520 AUSTRALIA TREATMENT IN BLAU SYNDROME , BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 521 AUSTRALIA ORAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 522 AUSTRALIA PARENTERAL BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 523 AUSTRALIA TOPICAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 524 AUSTRALIA BLAU SYNDROME MARKET, BY END USER, 2018-2027 (USD THOUSAND)
TABLE 525 AUSTRALIA BLAU SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
TABLE 526 SOUTH KOREA BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 527 SOUTH KOREA DIAGNOSIS IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 528 SOUTH KOREA SCREENING IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 529 SOUTH KOREA LAB TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 530 SOUTH KOREA IMAGING TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 531 SOUTH KOREA CONFIRMATORY TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 532 SOUTH KOREA TREATMENT IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 533 SOUTH KOREA CORTICOSTEROIDS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 534 SOUTH KOREA IMMUNOSUPPRESSANTS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 535 SOUTH KOREA TNF-Α INHIBITORS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 536 SOUTH KOREA OPHTHALMIC MEDICATION IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 537 SOUTH KOREA INTERLEUKIN RECEPTOR IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 538 SOUTH KOREA BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 539 SOUTH KOREA INFLAMMATION IN BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 540 SOUTH KOREA TREATMENT IN BLAU SYNDROME , BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 541 SOUTH KOREA ORAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 542 SOUTH KOREA PARENTERAL BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 543 SOUTH KOREA TOPICAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 544 SOUTH KOREA BLAU SYNDROME MARKET, BY END USER, 2018-2027 (USD THOUSAND)
TABLE 545 SOUTH KOREA BLAU SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
TABLE 546 INDIA BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 547 INDIA DIAGNOSIS IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 548 INDIA SCREENING IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 549 INDIA LAB TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 550 INDIA IMAGING TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 551 INDIA CONFIRMATORY TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 552 INDIA TREATMENT IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 553 INDIA CORTICOSTEROIDS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 554 INDIA IMMUNOSUPPRESSANTS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 555 INDIA TNF-Α INHIBITORS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 556 INDIA OPHTHALMIC MEDICATION IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 557 INDIA INTERLEUKIN RECEPTOR IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 558 INDIA BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 559 INDIA INFLAMMATION IN BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 560 INDIA TREATMENT IN BLAU SYNDROME , BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 561 INDIA ORAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 562 INDIA PARENTERAL BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 563 INDIA TOPICAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 564 INDIA BLAU SYNDROME MARKET, BY END USER, 2018-2027 (USD THOUSAND)
TABLE 565 INDIA BLAU SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
TABLE 566 SINGAPORE BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 567 SINGAPORE DIAGNOSIS IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 568 SINGAPORE SCREENING IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 569 SINGAPORE LAB TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 570 SINGAPORE IMAGING TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 571 SINGAPORE CONFIRMATORY TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 572 SINGAPORE TREATMENT IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 573 SINGAPORE CORTICOSTEROIDS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 574 SINGAPORE IMMUNOSUPPRESSANTS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 575 SINGAPORE TNF-Α INHIBITORS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 576 SINGAPORE OPHTHALMIC MEDICATION IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 577 SINGAPORE INTERLEUKIN RECEPTOR IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 578 SINGAPORE BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 579 SINGAPORE INFLAMMATION IN BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 580 SINGAPORE TREATMENT IN BLAU SYNDROME , BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 581 SINGAPORE ORAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 582 SINGAPORE PARENTERAL BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 583 SINGAPORE TOPICAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 584 SINGAPORE BLAU SYNDROME MARKET, BY END USER, 2018-2027 (USD THOUSAND)
TABLE 585 SINGAPORE BLAU SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
TABLE 586 MALAYSIA BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 587 MALAYSIA DIAGNOSIS IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 588 MALAYSIA SCREENING IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 589 MALAYSIA LAB TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 590 MALAYSIA IMAGING TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 591 MALAYSIA CONFIRMATORY TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 592 MALAYSIA TREATMENT IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 593 MALAYSIA CORTICOSTEROIDS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 594 MALAYSIA IMMUNOSUPPRESSANTS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 595 MALAYSIA TNF-Α INHIBITORS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 596 MALAYSIA OPHTHALMIC MEDICATION IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 597 MALAYSIA INTERLEUKIN RECEPTOR IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 598 MALAYSIA BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 599 MALAYSIA INFLAMMATION IN BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 600 MALAYSIA TREATMENT IN BLAU SYNDROME , BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 601 MALAYSIA ORAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 602 MALAYSIA PARENTERAL BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 603 MALAYSIA TOPICAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 604 MALAYSIA BLAU SYNDROME MARKET, BY END USER, 2018-2027 (USD THOUSAND)
TABLE 605 MALAYSIA BLAU SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
TABLE 606 THAILAND BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 607 THAILAND DIAGNOSIS IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 608 THAILAND SCREENING IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 609 THAILAND LAB TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 610 THAILAND IMAGING TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 611 THAILAND CONFIRMATORY TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 612 THAILAND TREATMENT IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 613 THAILAND CORTICOSTEROIDS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 614 THAILAND IMMUNOSUPPRESSANTS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 615 THAILAND TNF-Α INHIBITORS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 616 THAILAND OPHTHALMIC MEDICATION IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 617 THAILAND INTERLEUKIN RECEPTOR IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 618 THAILAND BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 619 THAILAND INFLAMMATION IN BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 620 THAILAND TREATMENT IN BLAU SYNDROME , BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 621 THAILAND ORAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 622 THAILAND PARENTERAL BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 623 THAILAND TOPICAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 624 THAILAND BLAU SYNDROME MARKET, BY END USER, 2018-2027 (USD THOUSAND)
TABLE 625 THAILAND BLAU SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
TABLE 626 INDONESIA BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 627 INDONESIA DIAGNOSIS IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 628 INDONESIA SCREENING IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 629 INDONESIA LAB TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 630 INDONESIA IMAGING TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 631 INDONESIA CONFIRMATORY TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 632 INDONESIA TREATMENT IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 633 INDONESIA CORTICOSTEROIDS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 634 INDONESIA IMMUNOSUPPRESSANTS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 635 INDONESIA TNF-Α INHIBITORS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 636 INDONESIA OPHTHALMIC MEDICATION IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 637 INDONESIA INTERLEUKIN RECEPTOR IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 638 INDONESIA BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 639 INDONESIA INFLAMMATION IN BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 640 INDONESIA TREATMENT IN BLAU SYNDROME , BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 641 INDONESIA ORAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 642 INDONESIA PARENTERAL BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 643 INDONESIA TOPICAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 644 INDONESIA BLAU SYNDROME MARKET, BY END USER, 2018-2027 (USD THOUSAND)
TABLE 645 INDONESIA BLAU SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
TABLE 646 MEXICO BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 647 PHILIPPINES DIAGNOSIS IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 648 PHILIPPINES SCREENING IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 649 PHILIPPINES LAB TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 650 PHILIPPINES IMAGING TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 651 PHILIPPINES CONFIRMATORY TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 652 PHILIPPINES TREATMENT IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 653 PHILIPPINES CORTICOSTEROIDS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 654 PHILIPPINES IMMUNOSUPPRESSANTS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 655 PHILIPPINES TNF-Α INHIBITORS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 656 PHILIPPINES OPHTHALMIC MEDICATION IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 657 PHILIPPINES INTERLEUKIN RECEPTOR IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 658 PHILIPPINES BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 659 PHILIPPINES INFLAMMATION IN BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 660 PHILIPPINES TREATMENT IN BLAU SYNDROME , BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 661 PHILIPPINES ORAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 662 PHILIPPINES PARENTERAL BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 663 PHILIPPINES TOPICAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 664 PHILIPPINES BLAU SYNDROME MARKET, BY END USER, 2018-2027 (USD THOUSAND)
TABLE 665 PHILIPPINES BLAU SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
TABLE 666 VIETNAM BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 667 VIETNAM DIAGNOSIS IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 668 VIETNAM SCREENING IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 669 VIETNAM LAB TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 670 VIETNAM IMAGING TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 671 VIETNAM CONFIRMATORY TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 672 VIETNAM TREATMENT IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 673 VIETNAM CORTICOSTEROIDS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 674 VIETNAM IMMUNOSUPPRESSANTS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 675 VIETNAM TNF-Α INHIBITORS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 676 VIETNAM OPHTHALMIC MEDICATION IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 677 VIETNAM INTERLEUKIN RECEPTOR IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 678 VIETNAM BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 679 VIETNAM INFLAMMATION IN BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 680 VIETNAM TREATMENT IN BLAU SYNDROME , BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 681 VIETNAM ORAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 682 VIETNAM PARENTERAL BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 683 VIETNAM TOPICAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 684 VIETNAM BLAU SYNDROME MARKET, BY END USER, 2018-2027 (USD THOUSAND)
TABLE 685 VIETNAM BLAU SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
TABLE 686 REST OF ASIA-PACIFIC BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 687 SOUTH AMERICA BLAU SYNDROME MARKET, BY COUNTRY, 2018-2027 (USD THOUSAND)
TABLE 688 SOUTH AMERICA BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 689 SOUTH AMERICA DIAGNOSIS IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 690 SOUTH AMERICA SCREENING IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 691 SOUTH AMERICA LAB TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 692 SOUTH AMERICA IMAGING TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 693 SOUTH AMERICA CONFIRMATORY TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 694 SOUTH AMERICA TREATMENT IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 695 SOUTH AMERICA CORTICOSTEROIDS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 696 SOUTH AMERICA IMMUNOSUPPRESSANTS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 697 SOUTH AMERICA TNF-Α INHIBITORS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 698 SOUTH AMERICA OPHTHALMIC MEDICATION IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 699 SOUTH AMERICA INTERLEUKIN RECEPTOR IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 700 SOUTH AMERICA BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 701 SOUTH AMERICA INFLAMMATION IN BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 702 SOUTH AMERICA TREATMENT IN BLAU SYNDROME , BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 703 SOUTH AMERICA ORAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 704 SOUTH AMERICA PARENTERAL BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 705 SOUTH AMERICA TOPICAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 706 SOUTH AMERICA BLAU SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
TABLE 707 SOUTH AMERICA BLAU SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
TABLE 708 BRAZIL BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 709 BRAZIL DIAGNOSIS IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 710 BRAZIL SCREENING IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 711 BRAZIL LAB TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 712 BRAZIL IMAGING TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 713 BRAZIL CONFIRMATORY TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 714 BRAZIL TREATMENT IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 715 BRAZIL CORTICOSTEROIDS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 716 BRAZIL IMMUNOSUPPRESSANTS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 717 BRAZIL TNF-Α INHIBITORS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 718 BRAZIL OPHTHALMIC MEDICATION IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 719 BRAZIL INTERLEUKIN RECEPTOR IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 720 BRAZIL BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 721 BRAZIL INFLAMMATION IN BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 722 BRAZIL TREATMENT IN BLAU SYNDROME , BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 723 BRAZIL ORAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 724 BRAZIL PARENTERAL BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 725 BRAZIL TOPICAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 726 BRAZIL BLAU SYNDROME MARKET, BY END USER, 2018-2027 (USD THOUSAND)
TABLE 727 BRAZIL BLAU SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
TABLE 728 ARGENTINA BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 729 ARGENTINA DIAGNOSIS IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 730 ARGENTINA SCREENING IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 731 ARGENTINA LAB TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 732 ARGENTINA IMAGING TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 733 ARGENTINA CONFIRMATORY TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 734 ARGENTINA TREATMENT IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 735 ARGENTINA CORTICOSTEROIDS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 736 ARGENTINA IMMUNOSUPPRESSANTS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 737 ARGENTINA TNF-Α INHIBITORS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 738 ARGENTINA OPHTHALMIC MEDICATION IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 739 ARGENTINA INTERLEUKIN RECEPTOR IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 740 ARGENTINA BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 741 ARGENTINA INFLAMMATION IN BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 742 ARGENTINA TREATMENT IN BLAU SYNDROME , BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 743 ARGENTINA ORAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 744 ARGENTINA PARENTERAL BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 745 ARGENTINA TOPICAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 746 ARGENTINA BLAU SYNDROME MARKET, BY END USER, 2018-2027 (USD THOUSAND)
TABLE 747 ARGENTINA BLAU SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
TABLE 748 PERU BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 749 PERU DIAGNOSIS IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 750 PERU SCREENING IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 751 PERU LAB TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 752 PERU IMAGING TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 753 PERU CONFIRMATORY TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 754 PERU TREATMENT IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 755 PERU CORTICOSTEROIDS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 756 PERU IMMUNOSUPPRESSANTS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 757 PERU TNF-Α INHIBITORS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 758 PERU OPHTHALMIC MEDICATION IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 759 PERU INTERLEUKIN RECEPTOR IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 760 PERU BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 761 PERU INFLAMMATION IN BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 762 PERU TREATMENT IN BLAU SYNDROME , BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 763 PERU ORAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 764 PERU PARENTERAL BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 765 PERU TOPICAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 766 PERU BLAU SYNDROME MARKET, BY END USER, 2018-2027 (USD THOUSAND)
TABLE 767 PERU BLAU SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
TABLE 768 REST OF SOUTH AMERICA BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 769 MIDDLE EAST & AFRICA BLAU SYNDROME MARKET, BY COUNTRY, 2018-2027 (USD THOUSAND)
TABLE 770 MIDDLE EAST & AFRICA BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 771 MIDDLE EAST & AFRICA DIAGNOSIS IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 772 MIDDLE EAST & AFRICA SCREENING IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 773 MIDDLE EAST & AFRICA LAB TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 774 MIDDLE EAST & AFRICA IMAGING TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 775 MIDDLE EAST & AFRICA CONFIRMATORY TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 776 MIDDLE EAST & AFRICA TREATMENT IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 777 MIDDLE EAST & AFRICA CORTICOSTEROIDS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 778 MIDDLE EAST & AFRICA IMMUNOSUPPRESSANTS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 779 MIDDLE EAST & AFRICA TNF-Α INHIBITORS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 780 MIDDLE EAST & AFRICA OPHTHALMIC MEDICATION IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 781 MIDDLE EAST & AFRICA INTERLEUKIN RECEPTOR IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 782 MIDDLE EAST & AFRICA BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 783 MIDDLE EAST & AFRICA INFLAMMATION IN BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 784 MIDDLE EAST & AFRICA TREATMENT IN BLAU SYNDROME , BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 785 MIDDLE EAST & AFRICA ORAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 786 MIDDLE EAST & AFRICA PARENTERAL BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 787 MIDDLE EAST & AFRICA TOPICAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 788 MIDDLE EAST & AFRICA BLAU SYNDROME MARKET, BY END USER, 2018-2027 (USD THOUSAND)
TABLE 789 MIDDLE EAST & AFRICA BLAU SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
TABLE 790 SAUDI ARABIA BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 791 SAUDI ARABIA DIAGNOSIS IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 792 SAUDI ARABIA SCREENING IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 793 SAUDI ARABIA LAB TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 794 SAUDI ARABIA IMAGING TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 795 SAUDI ARABIA CONFIRMATORY TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 796 SAUDI ARABIA TREATMENT IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 797 SAUDI ARABIA CORTICOSTEROIDS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 798 SAUDI ARABIA IMMUNOSUPPRESSANTS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 799 SAUDI ARABIA TNF-Α INHIBITORS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 800 SAUDI ARABIA OPHTHALMIC MEDICATION IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 801 SAUDI ARABIA INTERLEUKIN RECEPTOR IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 802 SAUDI ARABIA BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 803 SAUDI ARABIA INFLAMMATION IN BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 804 SAUDI ARABIA TREATMENT IN BLAU SYNDROME , BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 805 SAUDI ARABIA ORAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 806 SAUDI ARABIA PARENTERAL BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 807 JAPAN TOPICAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 808 SAUDI ARABIA BLAU SYNDROME MARKET, BY END USER, 2018-2027 (USD THOUSAND)
TABLE 809 SAUDI ARABIA BLAU SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
TABLE 810 SOUTH AFRICA BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 811 SOUTH AFRICA DIAGNOSIS IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 812 SOUTH AFRICA SCREENING IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 813 SOUTH AFRICA LAB TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 814 SOUTH AFRICA IMAGING TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 815 SOUTH AFRICA CONFIRMATORY TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 816 SOUTH AFRICA TREATMENT IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 817 SOUTH AFRICA CORTICOSTEROIDS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 818 SOUTH AFRICA IMMUNOSUPPRESSANTS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 819 SOUTH AFRICA TNF-Α INHIBITORS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 820 SOUTH AFRICA OPHTHALMIC MEDICATION IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 821 SOUTH AFRICA INTERLEUKIN RECEPTOR IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 822 SOUTH AFRICA BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 823 SOUTH AFRICA INFLAMMATION IN BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 824 SOUTH AFRICA TREATMENT IN BLAU SYNDROME , BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 825 SOUTH AFRICA ORAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 826 SOUTH AFRICA PARENTERAL BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 827 SOUTH AFRICA TOPICAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 828 SOUTH AFRICA BLAU SYNDROME MARKET, BY END USER, 2018-2027 (USD THOUSAND)
TABLE 829 SOUTH AFRICA BLAU SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
TABLE 830 UAE BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 831 UAE DIAGNOSIS IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 832 UAE SCREENING IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 833 UAE LAB TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 834 UAE IMAGING TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 835 UAE CONFIRMATORY TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 836 UAE TREATMENT IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 837 UAE CORTICOSTEROIDS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 838 UAE IMMUNOSUPPRESSANTS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 839 UAE TNF-Α INHIBITORS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 840 UAE OPHTHALMIC MEDICATION IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 841 UAE INTERLEUKIN RECEPTOR IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 842 UAE BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 843 UAE INFLAMMATION IN BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 844 UAE TREATMENT IN BLAU SYNDROME , BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 845 UAE ORAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 846 UAE PARENTERAL BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 847 UAE TOPICAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 848 UAE BLAU SYNDROME MARKET, BY END USER, 2018-2027 (USD THOUSAND)
TABLE 849 UAE BLAU SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
TABLE 850 ISRAEL BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 851 ISRAEL DIAGNOSIS IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 852 ISRAEL SCREENING IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 853 ISRAEL LAB TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 854 ISRAEL IMAGING TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 855 ISRAEL CONFIRMATORY TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 856 ISRAEL TREATMENT IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 857 ISRAEL CORTICOSTEROIDS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 858 ISRAEL IMMUNOSUPPRESSANTS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 859 ISRAEL TNF-Α INHIBITORS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 860 ISRAEL OPHTHALMIC MEDICATION IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 861 ISRAEL INTERLEUKIN RECEPTOR IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 862 ISRAEL BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 863 ISRAEL INFLAMMATION IN BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 864 ISRAEL TREATMENT IN BLAU SYNDROME , BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 865 ISRAEL ORAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 866 ISRAEL PARENTERAL BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 867 ISRAEL TOPICAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 868 ISRAEL BLAU SYNDROME MARKET, BY END USER, 2018-2027 (USD THOUSAND)
TABLE 869 ISRAEL BLAU SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
TABLE 870 KUWAIT BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 871 KUWAIT DIAGNOSIS IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 872 KUWAIT SCREENING IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 873 KUWAIT LAB TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 874 KUWAIT IMAGING TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 875 KUWAIT CONFIRMATORY TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 876 KUWAIT TREATMENT IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 877 KUWAIT CORTICOSTEROIDS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 878 KUWAIT IMMUNOSUPPRESSANTS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 879 KUWAIT TNF-Α INHIBITORS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 880 KUWAIT OPHTHALMIC MEDICATION IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 881 KUWAIT INTERLEUKIN RECEPTOR IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 882 KUWAIT BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 883 KUWAIT INFLAMMATION IN BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 884 KUWAIT TREATMENT IN BLAU SYNDROME , BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 885 KUWAIT ORAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 886 KUWAIT PARENTERAL BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 887 KUWAIT TOPICAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 888 KUWAIT BLAU SYNDROME MARKET, BY END USER, 2018-2027 (USD THOUSAND)
TABLE 889 KUWAIT BLAU SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
TABLE 890 EGYPT BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 891 EGYPT DIAGNOSIS IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 892 EGYPT SCREENING IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 893 EGYPT LAB TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 894 EGYPT IMAGING TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 895 EGYPT CONFIRMATORY TEST IN BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)
TABLE 896 EGYPT TREATMENT IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 897 EGYPT CORTICOSTEROIDS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 898 EGYPT IMMUNOSUPPRESSANTS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 899 EGYPT TNF-Α INHIBITORS IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 900 EGYPT OPHTHALMIC MEDICATION IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 901 EGYPT INTERLEUKIN RECEPTOR IN BLAU SYNDROME MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
TABLE 902 EGYPT BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 903 EGYPT INFLAMMATION IN BLAU SYNDROME MARKET, BY THERAPEUTIC AREAS, 2018-2027 (USD THOUSAND)
TABLE 904 EGYPT TREATMENT IN BLAU SYNDROME , BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 905 EGYPT ORAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 906 EGYPT PARENTERAL BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 907 EGYPT TOPICAL IN BLAU SYNDROME MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
TABLE 908 EGYPT BLAU SYNDROME MARKET, BY END USER, 2018-2027 (USD THOUSAND)
TABLE 909 EGYPT BLAU SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
TABLE 910 REST OF MIDDLE EAST & AFRICA BLAU SYNDROME MARKET, BY TYPE 2018-2027 (USD THOUSAND)